Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Zollinger-Ellison Syndrome 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia 1Leukemia, B-Cell 1Helicobacter Infections 1Gastritis, Atrophic 1Esophagitis, Peptic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

vandetanib 1gallium Ga 68 dotatate 1fluorodopa F 18 1Surveys and Questionnaires 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Lansoprazole 1Immunotherapy 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Multiple Endocrine Neoplasia × Lansoprazole × Clear all
NCT00204373 2012-10-30

Treatment of Zollinger-Ellison Syndrome With Prevacid

University of Alabama at Birmingham

Phase 4 Completed
72 enrolled 8 charts
Endocrine

Multiple Endocrine Neoplasia, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡